Learning Objective:
Understand the mechanism of action, clinical uses, side effects, and contraindications of ranolazine in cardiac patients.
Mechanism of Action
- Primary effect:
Blocks late inward Na⁺ current in cardiac myocytes → ↓ intracellular Na⁺ → ↓ Ca²⁺ accumulation → reduces myocardial oxygen demand. - Secondary effect: Mild K⁺ channel blockade affecting repolarization.
Activity
Clinical Effects / Use
- Used mainly for chronic stable angina.
- Improves symptoms without significantly affecting heart rate or blood pressure.
Activity
Side Effects
- Most common: constipation, nausea
- Other: QT interval prolongation → risk of arrhythmias
Contraindications
- Congenital long QT syndrome
- Concurrent use of drugs that increase the QT interval
- Clinical pearl: Check electrolytes (Mg²⁺, K⁺) before therapy.

Activity

High-Yield Summary Table
| Feature | Details | Color Highlight |
|---|---|---|
| Mechanism | Blocks late Na⁺ current → ↓ Ca²⁺ → ↓ O₂ demand; mild K⁺ blockade | Na⁺ & Ca²⁺, O₂ |
| Use | Chronic stable angina | green |
| Side effects | Constipation, nausea, QT prolongation | constipation/nausea, QT |
| Contraindications | Long QT syndrome, QT-prolonging drugs | red |









You must be logged in to post a comment.